PDCD1 and COVID-19: Furthermore, in patients suffering from severe coronavirus disease 2019 (COVID-19), in addition to a reduction in the number of peripheral-blood T cells [24–28], the proportion of PD-1 expression in the remaining T cells is very high [27, 28].